vs
BRADY CORP(BRC)与Concentra Group Holdings Parent, Inc.(CON)财务数据对比。点击上方公司名可切换其他公司
Concentra Group Holdings Parent, Inc.的季度营收约是BRADY CORP的1.4倍($569.6M vs $405.3M),BRADY CORP净利率更高(13.3% vs 9.2%,领先4.1%),Concentra Group Holdings Parent, Inc.同比增速更快(13.7% vs 7.5%),BRADY CORP自由现金流更多($22.4M vs $9.9M)
布雷迪公司是美国特种产品、技术设备及标识解决方案供应商,1914年创立,总部位于威斯康星州密尔沃基,在美洲、欧洲、亚洲、澳洲拥有6600名员工,业务覆盖全球,为各行业客户提供工作场景所需的零部件标识相关产品与服务。
Concentra是美国的职业医疗服务商,1979年成立于得克萨斯州阿马里洛,总部位于得克萨斯州艾迪生。业务覆盖美国47个州,运营627家职业医疗中心和410个雇主驻地现场诊所,美国每7起职业伤害案例中就有1起由该机构提供诊疗服务。
BRC vs CON — 直观对比
营收规模更大
CON
是对方的1.4倍
$405.3M
营收增速更快
CON
高出6.3%
7.5%
净利率更高
BRC
高出4.1%
9.2%
自由现金流更多
BRC
多$12.4M
$9.9M
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $405.3M | $569.6M |
| 净利润 | $53.9M | $52.3M |
| 毛利率 | 51.5% | — |
| 营业利润率 | 16.8% | 16.8% |
| 净利率 | 13.3% | 9.2% |
| 营收同比 | 7.5% | 13.7% |
| 净利润同比 | 15.3% | 28.7% |
| 每股收益(稀释后) | — | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BRC
CON
| Q1 26 | — | $569.6M | ||
| Q4 25 | $405.3M | $539.1M | ||
| Q3 25 | $397.3M | $572.8M | ||
| Q2 25 | $382.6M | $550.8M | ||
| Q1 25 | $356.7M | $500.8M | ||
| Q4 24 | $377.1M | — | ||
| Q3 24 | $343.4M | $489.6M | ||
| Q2 24 | $343.4M | $477.9M |
净利润
BRC
CON
| Q1 26 | — | $52.3M | ||
| Q4 25 | $53.9M | $34.7M | ||
| Q3 25 | $49.9M | $48.3M | ||
| Q2 25 | $52.3M | $44.6M | ||
| Q1 25 | $40.3M | $38.9M | ||
| Q4 24 | $46.8M | — | ||
| Q3 24 | $55.5M | $44.3M | ||
| Q2 24 | $50.9M | $51.7M |
毛利率
BRC
CON
| Q1 26 | — | — | ||
| Q4 25 | 51.5% | — | ||
| Q3 25 | 50.4% | — | ||
| Q2 25 | 51.0% | — | ||
| Q1 25 | 49.3% | — | ||
| Q4 24 | 50.3% | — | ||
| Q3 24 | 51.6% | — | ||
| Q2 24 | 51.6% | — |
营业利润率
BRC
CON
| Q1 26 | — | 16.8% | ||
| Q4 25 | 16.8% | 12.9% | ||
| Q3 25 | 14.9% | 16.5% | ||
| Q2 25 | 17.6% | 16.3% | ||
| Q1 25 | 14.4% | 16.0% | ||
| Q4 24 | 15.6% | — | ||
| Q3 24 | 19.3% | 17.6% | ||
| Q2 24 | 18.5% | 17.6% |
净利率
BRC
CON
| Q1 26 | — | 9.2% | ||
| Q4 25 | 13.3% | 6.4% | ||
| Q3 25 | 12.6% | 8.4% | ||
| Q2 25 | 13.7% | 8.1% | ||
| Q1 25 | 11.3% | 7.8% | ||
| Q4 24 | 12.4% | — | ||
| Q3 24 | 16.1% | 9.1% | ||
| Q2 24 | 14.8% | 10.8% |
每股收益(稀释后)
BRC
CON
| Q1 26 | — | $0.39 | ||
| Q4 25 | — | $0.27 | ||
| Q3 25 | — | $0.38 | ||
| Q2 25 | — | $0.35 | ||
| Q1 25 | — | $0.30 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0.37 | ||
| Q2 24 | — | $0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $182.7M | — |
| 总债务越低越好 | $115.9M | $1.6B |
| 股东权益账面价值 | $1.2B | $424.7M |
| 总资产 | $1.8B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.09× | 3.68× |
8季度趋势,按日历期对齐
现金及短期投资
BRC
CON
| Q1 26 | — | — | ||
| Q4 25 | $182.7M | $79.9M | ||
| Q3 25 | $174.3M | $49.9M | ||
| Q2 25 | $152.2M | $73.9M | ||
| Q1 25 | $138.5M | $52.1M | ||
| Q4 24 | $145.7M | — | ||
| Q3 24 | $250.1M | $136.8M | ||
| Q2 24 | $160.5M | $50.7M |
总债务
BRC
CON
| Q1 26 | — | $1.6B | ||
| Q4 25 | $115.9M | $1.6B | ||
| Q3 25 | $99.8M | $1.6B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | — | ||
| Q3 24 | $90.9M | $1.5B | ||
| Q2 24 | — | $3.0M |
股东权益
BRC
CON
| Q1 26 | — | $424.7M | ||
| Q4 25 | $1.2B | $393.3M | ||
| Q3 25 | $1.2B | $385.5M | ||
| Q2 25 | $1.2B | $342.6M | ||
| Q1 25 | $1.1B | $307.1M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | $277.8M | ||
| Q2 24 | $1.0B | $1.2B |
总资产
BRC
CON
| Q1 26 | — | $2.9B | ||
| Q4 25 | $1.8B | $2.9B | ||
| Q3 25 | $1.7B | $2.8B | ||
| Q2 25 | $1.7B | $2.8B | ||
| Q1 25 | $1.6B | $2.7B | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.5B | $2.5B | ||
| Q2 24 | $1.4B | $2.4B |
负债/权益比
BRC
CON
| Q1 26 | — | 3.68× | ||
| Q4 25 | 0.09× | 3.98× | ||
| Q3 25 | 0.08× | 4.15× | ||
| Q2 25 | — | 4.82× | ||
| Q1 25 | — | 5.27× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.09× | 5.30× | ||
| Q2 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $33.4M | $21.0M |
| 自由现金流经营现金流 - 资本支出 | $22.4M | $9.9M |
| 自由现金流率自由现金流/营收 | 5.5% | 1.7% |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | 0.62× | 0.40× |
| 过去12个月自由现金流最近4个季度 | $159.9M | $211.0M |
8季度趋势,按日历期对齐
经营现金流
BRC
CON
| Q1 26 | — | $21.0M | ||
| Q4 25 | $33.4M | $118.7M | ||
| Q3 25 | $58.3M | $60.6M | ||
| Q2 25 | $59.9M | $88.4M | ||
| Q1 25 | $39.6M | $11.7M | ||
| Q4 24 | $23.4M | — | ||
| Q3 24 | $84.0M | $65.9M | ||
| Q2 24 | $72.7M | — |
自由现金流
BRC
CON
| Q1 26 | — | $9.9M | ||
| Q4 25 | $22.4M | $98.5M | ||
| Q3 25 | $49.4M | $39.4M | ||
| Q2 25 | $55.6M | $63.2M | ||
| Q1 25 | $32.5M | $-4.0M | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $73.2M | $50.8M | ||
| Q2 24 | $64.4M | — |
自由现金流率
BRC
CON
| Q1 26 | — | 1.7% | ||
| Q4 25 | 5.5% | 18.3% | ||
| Q3 25 | 12.4% | 6.9% | ||
| Q2 25 | 14.5% | 11.5% | ||
| Q1 25 | 9.1% | -0.8% | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 21.3% | 10.4% | ||
| Q2 24 | 18.8% | — |
资本支出强度
BRC
CON
| Q1 26 | — | — | ||
| Q4 25 | 2.7% | 3.7% | ||
| Q3 25 | 2.2% | 3.7% | ||
| Q2 25 | 1.1% | 4.6% | ||
| Q1 25 | 2.0% | 3.1% | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 3.1% | 3.1% | ||
| Q2 24 | 2.4% | — |
现金转化率
BRC
CON
| Q1 26 | — | 0.40× | ||
| Q4 25 | 0.62× | 3.42× | ||
| Q3 25 | 1.17× | 1.26× | ||
| Q2 25 | 1.15× | 1.98× | ||
| Q1 25 | 0.98× | 0.30× | ||
| Q4 24 | 0.50× | — | ||
| Q3 24 | 1.51× | 1.49× | ||
| Q2 24 | 1.43× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRC
| Americas Asia | $215.1M | 53% |
| Europe Australia | $119.9M | 30% |
| Other | $70.2M | 17% |
CON
| Workers' compensation | $337.7M | 59% |
| Employer services | $172.4M | 30% |
| Onsite health clinics | $37.2M | 7% |
| Other | $14.5M | 3% |
| Consumer health | $7.8M | 1% |